Is there a role for SGLT-2 inhibitors in the treatment of chronic hypomagnesemia?

What is your view on the role of SGLT-2 inhibitors in treating chronic hypomagnesemia, based on current evidence?

• They should be considered a primary treatment option due to their significant impact on serum magnesium levels.
• Their use as a treatment should be secondary to established therapies until further clinical trials are conducted.
• The evidence is too preliminary to consider them in the treatment protocol for chronic hypomagnesemia.
• Other